Invention Grant
- Patent Title: Insulin derivatives with a terminal LPXT motif
-
Application No.: US16719788Application Date: 2019-12-18
-
Publication No.: US11261228B2Publication Date: 2022-03-01
- Inventor: Arri Russell Morris
- Applicant: Arri Russell Morris
- Applicant Address: US TX Austin
- Assignee: Arri Russell Morris
- Current Assignee: Arri Russell Morris
- Current Assignee Address: US TX Austin
- Agency: Hulsey P.C.
- Main IPC: C07K14/62
- IPC: C07K14/62 ; A61K38/28 ; A61P3/10 ; C12P21/02

Abstract:
The present invention relates to insulin derivatives which, in comparison to insulin glulisine and similar derivatives, has a simplified process for synthesis. In particular, the present invention relates to insulin derivatives or physiologically tolerable salts thereof in which the motif Leucine-Proline-X-Threonine appears at the end of the B-chain, where X is any amino acid residue. Due to the nature of the process, the A-chain and B-chain must begin with a Glycine amino acid residue.
Public/Granted literature
- US20210188938A1 Insulin derivatives with a terminal LPXT motif Public/Granted day:2021-06-24
Information query